In accordance with Article 14.5 of the World Anti-Doping Code (the Code), WADA, acting as a central clearinghouse for Doping Control data, annually publishes statistical reports as reported by the WADA accredited laboratories in the Anti-Doping Administration and Management System (ADAMS).
The 2013 WADA Anti-Doping Testing Figures Report is represented in four separate reports, namely Laboratory Report, Sport Report, Testing Authority Report and ABP Report-Blood Analysis, and includes analyses by WADA accredited laboratories (in 2013) for in- and out-of-competition Urine, Blood and Blood Passport testing.Of note:
1. Table 2 of the "Testing Authority Report" (TAR) shows that, in 2013, ITF testing resulted in 2 Atypical Findings and 12 Adverse Analytical Findings. By my count, in 2013, the ITF issued 6 anti-doping violations based on its testing program (2 additional violations came from national anti-doping bodies). This leaves 6 ITF testing adverse findings unaccounted (potential reasons for the difference are the hearing is still ongoing, athlete was exonerated, or athlete had a valid therapeutic use exemption).
2. Table 12 of the TAR shows that the ITF conducted 101 Gas Chromatograph/Carbon/Isotope Ratio Mass Spectrometer (e.g."IRMS") tests (i.e., synthetic testosterone). The samples were split 94 in-competition samples and 7 out-of-competition samples. No adverse or atypical findings.
3. Table 13 of the TAR shows the ITF conducted 123 EPO tests (112 in-comp; 11 out-of-comp). No adverse or atypical findings.
4. Table 14 of the TAR: ITF conducted 139 hGH tests (170 in-comp; 69 out-of-comp). No adverse or atypical findings.
5. Table 47 of the TAR: Shows all tests for tennis across all anti-doping authorities. The ITF conducted 73.7% of all tennis anti-doping controls.
6. Table 41 of the ABP Report: Shows blood passport testing figures for tennis. The ITF collected 263 samples (96 in-comp; 167 out-of-comp). An additional 38 passport samples were collected by other anti-doping agencies for a grand total of 301.